Hims & Hers gains as FDA panel endorses peptide BPC-157 (HIMS) - Seeking Alpha
Кратко: Shares of Hims & Hers Health (HIMS) rose more than 10% on Thursday after an FDA advisory panel âvoted to include a popular peptide known as âBPC-157 in a list of molecules that compounding pharmacies are permitted to use
Shares of Hims & Hers Health (HIMS) rose more than 10% on Thursday after an FDA advisory panel âvoted to include a popular peptide known as âBPC-157 in a list of molecules that compounding pharmacies are permitted to use
🧭 Извлечение: ok
· confidence 90%
· диагностика
High confidence: full text extraction produced 441 characters.
High confidence: full text extraction produced 441 characters.
Shares of Hims & Hers Health (HIMS) rose more than 10% on Thursday after an FDA advisory panel âvoted to include a popular peptide known as âBPC-157 in a list of molecules that compounding pharmacies are permitted to use
Shares of Hims & Hers Health (HIMS) rose more than 10% on Thursday after an FDA advisory panel âvoted to include a popular peptide known as âBPC-157 in a list of molecules that compounding pharmacies are permitted to use